Literature DB >> 11964143

Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool.

Or Kakhlon1, Yosef Gruenbaum, Z Ioav Cabantchik.   

Abstract

Repression or overexpression of ferritin accelerated or retarded cell cycling respectively, via changes in the cellular labile iron pool (LIP). A rise in LIP is caused by ferritin repression enhanced growth, induced by H-ras, and reverted growth arrest is induced by dominant negative H-ras. The studies indicate that repression of ferritin expression provides a mechanism by which certain oncogenes lead to cell growth stimulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964143      PMCID: PMC1222495          DOI: 10.1042/0264-6021:3630431

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Ferritin expression in maturing normal human erythroid precursors.

Authors:  B Vaisman; E G Meyron-Holtz; E Fibach; A M Krichevsky; A M Konijn
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

2.  Cellular uptake and efficacy of antisense oligonucleotides against RNAs of two Na(+) channel isoforms.

Authors:  H Keller; B Schu; R Rüdel; H Brinkmeier
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells.

Authors:  O Kakhlon; Y Gruenbaum; Z I Cabantchik
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  Gcn2 mediates Gcn4 activation in response to glucose stimulation or UV radiation not via GCN4 translation.

Authors:  I Marbach; R Licht; H Frohnmeyer; D Engelberg
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

5.  Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.

Authors:  L A Tong; A M de Vos; M V Milburn; S H Kim
Journal:  J Mol Biol       Date:  1991-02-05       Impact factor: 5.469

6.  An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro.

Authors:  P M Pahl; X D Yan; Y K Hodges; E A Rosenthal; M A Horwitz; L D Horwitz
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

7.  The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression.

Authors:  J Gao; D R Richardson
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

8.  Inhibitory effect of mimosine on proliferation of human lung cancer cells is mediated by multiple mechanisms.

Authors:  H C Chang; T H Lee; L Y Chuang; M H Yen; W C Hung
Journal:  Cancer Lett       Date:  1999-10-18       Impact factor: 8.679

9.  The synthesis and turnover of ferritin in rat L-6 cells. Rates and response to iron, actinomycin D, and desferrioxamine.

Authors:  S R Rittling; R C Woodworth
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

10.  Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis.

Authors:  S Eriksson; A Gräslund; S Skog; L Thelander; B Tribukait
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

View more
  23 in total

1.  Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.

Authors:  Zhimin Gu; He Wang; Jiliang Xia; Ye Yang; Zhendong Jin; Hongwei Xu; Jumei Shi; Ivana De Domenico; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

2.  Ferroportin and iron regulation in breast cancer progression and prognosis.

Authors:  Zandra K Pinnix; Lance D Miller; Wei Wang; Ralph D'Agostino; Tim Kute; Mark C Willingham; Heather Hatcher; Lia Tesfay; Guangchao Sui; Xiumin Di; Suzy V Torti; Frank M Torti
Journal:  Sci Transl Med       Date:  2010-08-04       Impact factor: 17.956

Review 3.  Regulation of cellular iron metabolism and its implications in lung cancer progression.

Authors:  Wei Xiong; Li Wang; Fenglei Yu
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

Review 4.  Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.

Authors:  Shenghang Wang; Jie Luo; Zhihao Zhang; Dandan Dong; Ying Shen; Yanwen Fang; Lijiang Hu; Mengyu Liu; Chengfu Dai; Songlin Peng; Zhicai Fang; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

Review 5.  Insect ferritins: Typical or atypical?

Authors:  Daphne Q D Pham; Joy J Winzerling
Journal:  Biochim Biophys Acta       Date:  2010-03-15

Review 6.  Role of dietary iron revisited: in metabolism, ferroptosis and pathophysiology of cancer.

Authors:  Santhi Latha Pandrangi; Prasanthi Chittineedi; Rajasekhar Chikati; Joji Reddy Lingareddy; Meeravali Nagoor; Suresh Kumar Ponnada
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 7.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

8.  PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.

Authors:  Kenta Iwasaki; Kiros Hailemariam; Yoshiaki Tsuji
Journal:  J Biol Chem       Date:  2007-06-12       Impact factor: 5.157

Review 9.  Iron and Cancer: 2020 Vision.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

10.  Epigenomic regulation by labile iron.

Authors:  Vladimir Camarena; Tyler C Huff; Gaofeng Wang
Journal:  Free Radic Biol Med       Date:  2021-01-22       Impact factor: 8.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.